|Articles|October 7, 2014

Almac Expands its UK Commercial Packaging Facility

Almac expands its blister-packaging suite to meet the needs of two Japanese clients.

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance. Subscribe to Pharmaceutical Technology and never miss an industry breakthrough.

Subscribe

Related Content

PharmTech Weekly Roundup—August 7, 2026

BySusan Haigney

August 7th 2026

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

ByPartha S. Anbil,Deepak Manjarekar

August 7th 2026

melanoma diagnosis. the doctor examines the patient's mole | Image Credit: ©Evgeniy Kalinovskiy -stock.adobe.com

The FDA Gives Accelerated Approval to Melanoma Treatment

BySusan Haigney

August 7th 2026

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part Two

ByRichard Jaenisch,Christopher Cole

August 7th 2026

The Implications of Orzeyful (oveporexton) approval by the FDA

Why the Orzeyful Approval Matters Beyond One Drug Class

ByZachary Zubulake

August 6th 2026

Almac Expands its UK Commercial Packaging Facility

Related Content

PharmTech Weekly Roundup—August 7, 2026

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

The FDA Gives Accelerated Approval to Melanoma Treatment

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part Two

Why the Orzeyful Approval Matters Beyond One Drug Class

Trending on Pharmaceutical Technology

From Warehouse to Lakehouse: A Life Sciences Playbook for Regulated, AI-Ready Data Modernization

PharmTech Weekly Roundup—August 7, 2026

The FDA Gives Accelerated Approval to Melanoma Treatment

What Does Moderna's mRNA Flu Vaccine Approval Signal?

Manufacturing Intelligence: Sizing Up Pharma's Biggest AI Deals, Part Two